Thursday, September 28, 2017

Tax reform could spark a wave of biopharma M&A

CNBC's Meg Tirrell discusses the failed attempts at Pfizer trying to acquire two companies in the past but how the Republican tax reform plan could change that. The “Fast Money” traders weigh in.

from Mergers and Acquisitions http://ift.tt/2xErKAB

No comments:

Post a Comment